Bana Mohamad

As seen in: eCancer

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bana

Contact Bana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria

Jan 22, 2026 |

By Maher Saifo, Bana Mohamad

| eCancer

Background: Bevacizumab combined with chemotherapy has become a standard first-line treatment for advanced cervical cancer following the Gynecologic Oncology Group (GOG)-240 trial. However, real-world data from low-resource settings, such as Syria, remain limited.

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Bana

Contact Bana, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Bana Mohamad

Get in touch with Bana

Actions

Is this you?

Articles

Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria

Actions

Is this you?

Get in touch with Bana